What Researchers Did
Researchers conducted a systematic review of scientific literature to update clinical practice guidelines for managing mucositis, a common side effect of cancer therapy.
What They Found
The literature search identified 8279 papers, with 570 ultimately included for detailed evaluation. This extensive review led to the development of 16 new guidelines, bringing the total number of MASCC/ISOO mucositis guidelines to 32, including 22 for oral mucositis and 10 for gastrointestinal mucositis.
What This Means for Canadian Patients
For Canadian patients undergoing cancer treatment, these updated guidelines provide clinicians with evidence-based strategies to manage mucositis. This can help reduce pain and discomfort, potentially improving patient quality of life and their ability to complete necessary cancer therapies.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The guidelines are based on the scientific literature available at the time of the review, and the quality of the included studies may vary.